Integral Ad Science Swings to Loss Despite Revenue Growth

TL;DR

IAS's revenue growth is overshadowed by a concerning swing to net loss, signaling potential profitability issues that investors should scrutinize.

AI Summary

INTEGRAL AD SCIENCE HOLDING CORP. reported a net loss of $1.5 million for the three months ended June 30, 2025, a significant decline from the net income of $1.1 million in the prior-year period. For the six months ended June 30, 2025, the company posted a net loss of $1.1 million, compared to a net income of $2.2 million in the same period of 2024. Total revenues for the three months ended June 30, 2025, were $125.3 million, an increase of 10.5% from $113.4 million in the second quarter of 2024. Year-to-date revenues reached $245.8 million, up 9.8% from $223.9 million in the first half of 2024. The company's accumulated other comprehensive income decreased by $0.2 million in Q2 2025, contributing to the overall shift in profitability. Despite revenue growth, increased operating expenses and other factors led to the net loss, indicating potential challenges in cost management or investment returns. The strategic outlook remains focused on revenue expansion, but profitability is a near-term concern.

Why It Matters

This shift from net income to net loss, despite revenue growth, signals potential margin compression or increased operational costs for INTEGRAL AD SCIENCE HOLDING CORP., which could impact investor confidence. For employees, this might suggest a period of tighter financial scrutiny, while customers could see continued investment in ad verification technology. In the competitive ad tech landscape, where companies like DoubleVerify are vying for market share, a decline in profitability could weaken IAS's position and ability to innovate, potentially affecting its long-term market valuation.

Risk Assessment

Risk Level: medium — The company reported a net loss of $1.5 million for Q2 2025, a significant downturn from a $1.1 million net income in Q2 2024. This shift, despite a 10.5% revenue increase to $125.3 million, indicates potential challenges in cost control or increasing operational expenses, elevating the financial risk for investors.

Analyst Insight

Investors should closely monitor INTEGRAL AD SCIENCE HOLDING CORP.'s upcoming earnings calls for detailed explanations on the net loss and strategies to restore profitability. Consider holding existing positions but deferring new investments until a clear path to sustained net income is demonstrated, especially given the competitive ad tech market.

Financial Highlights

revenue

$125.3M

net Income

-$1.5M

revenue Growth

+10.5%

Key Numbers

• $1.5M — Net Loss (Q2 2025 net loss, a swing from $1.1M net income in Q2 2024)
• $125.3M — Total Revenues (Q2 2025 revenues, up 10.5% from Q2 2024)
• 10.5% — Revenue Growth (Percentage increase in Q2 2025 revenues compared to Q2 2024)
• $1.1M — Year-to-Date Net Loss (H1 2025 net loss, compared to $2.2M net income in H1 2024)
• $245.8M — Year-to-Date Revenues (H1 2025 revenues, up 9.8% from H1 2024)
• 9.8% — Year-to-Date Revenue Growth (Percentage increase in H1 2025 revenues compared to H1 2024)
• $0.2M — Accumulated Other Comprehensive Income Decrease (Decrease in Q2 2025, impacting overall profitability)

Key Players & Entities

• INTEGRAL AD SCIENCE HOLDING CORP. (company) — filer of the 10-Q
• DoubleVerify (company) — competitor in ad tech market
• $1.5 million (dollar_amount) — net loss for Q2 2025
• $1.1 million (dollar_amount) — net income for Q2 2024 and net loss for H1 2025
• $125.3 million (dollar_amount) — total revenues for Q2 2025
• $113.4 million (dollar_amount) — total revenues for Q2 2024
• 10.5% (percentage) — revenue increase from Q2 2024 to Q2 2025
• $245.8 million (dollar_amount) — year-to-date revenues for H1 2025
• $223.9 million (dollar_amount) — year-to-date revenues for H1 2024
• 9.8% (percentage) — year-to-date revenue increase from H1 2024 to H1 2025

FAQ

Industry Context

Integral Ad Science operates in the digital advertising verification and measurement industry. This sector is characterized by rapid technological advancements and increasing demand for ad fraud prevention, brand safety, and performance analytics. Key trends include the growth of programmatic advertising, the rise of CTV (Connected TV) advertising, and the ongoing need for data privacy compliance.

Regulatory Implications

The digital advertising industry is subject to evolving privacy regulations globally, such as GDPR and CCPA. Companies like Integral Ad Science must ensure their data collection and processing practices are compliant, which can impact their service offerings and operational costs. Changes in advertising platform policies also pose a regulatory risk.

What Investors Should Do

1. Monitor operating expense trends closely.
2. Evaluate the sustainability of revenue growth.

Glossary

Accumulated Other Comprehensive Income

Represents unrealized gains and losses that have not been recognized in net income. These can include foreign currency translation adjustments, pension adjustments, and unrealized gains/losses on certain investments. (A decrease in this account, as seen with the $0.2 million reduction in Q2 2025, can impact the overall equity of the company and may reflect market fluctuations or currency impacts.)

Year-Over-Year Comparison

Compared to the prior year's second quarter, Integral Ad Science Holding Corp. has seen a significant shift from a net income of $1.1 million to a net loss of $1.5 million, despite a healthy 10.5% increase in total revenues to $125.3 million. This indicates a deterioration in profitability, likely due to increased operating expenses or other costs that have outpaced revenue gains. The accumulated other comprehensive income also saw a decrease of $0.2 million, further contributing to the negative swing in overall financial performance.

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value per share IAS The NASDAQ Stoc

Filing Documents

• ias-20250630.htm (10-Q) — 1291KB
• ex-103xalpanarsuagreement.htm (EX-10.3) — 140KB
• ex-311q225.htm (EX-31.1) — 10KB
• ex-312q225.htm (EX-31.2) — 10KB
• ex-321q225.htm (EX-32.1) — 6KB
• ex-322q225.htm (EX-32.2) — 4KB
• ias-20250630_g1.jpg (GRAPHIC) — 19KB
• 0001842718-25-000098.txt ( ) — 7530KB
• ias-20250630.xsd (EX-101.SCH) — 48KB
• ias-20250630_cal.xml (EX-101.CAL) — 69KB
• ias-20250630_def.xml (EX-101.DEF) — 218KB
• ias-20250630_lab.xml (EX-101.LAB) — 645KB
• ias-20250630_pre.xml (EX-101.PRE) — 444KB
• ias-20250630_htm.xml (XML) — 1084KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Condensed Consolidated Financial Statements (Unaudited)

Item 1. Condensed Consolidated Financial Statements (Unaudited) Condensed Consolidated Balance Sheets as of June 30, 202 5 (Unaudited) and December 31, 20 24 3 Condensed Consolidated Statements of Operations and Comprehensive Income for the Three and Six Months Ended June 30, 2025 and 2024 (Unaudited) 4 Condensed Consolidated Statements of Changes in Stockholders' Equity for the Three and Six Months Ended June 30, 202 5 and 202 4 (Unaudited) 5 Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 202 5 and 202 4 (Unaudited) 7 Notes to the Condensed Consolidated Financial Statements (Unaudited) 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 23

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 36

Controls and Procedures

Item 4. Controls and Procedures 36

OTHER INFORMATION

PART II. OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 38

Risk Factors

Item 1A. Risk Factors 38

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 38

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 38

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 38

Other Information

Item 5. Other Information 38

Exhibits

Item 6. Exhibits 39

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements INTEGRAL AD SCIENCE HOLDING CORP. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (IN THOUSANDS, EXCEPT SHARE DATA) June 30, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 90,687 $ 84,469 Restricted cash 549 506 Accounts receivable, net of allowance for credit losses of $ 4,561 and $ 7,454 as of June 30, 2025 and December 31, 2024, respectively 79,561 79,427 Unbilled receivables 51,576 53,388 Prepaid expenses and other current assets 46,125 36,639 Due from related party 7 28 Total current assets 268,505 254,457 Property and equipment, net 3,880 4,004 Internal use software, net 59,923 53,636 Intangible assets, net 124,204 140,943 Goodwill 677,752 673,025 Operating lease right-of-use assets, net 23,076 17,888 Deferred tax asset, net 6,198 1,675 Other long-term assets 8,711 5,943 Total assets $ 1,172,249 $ 1,151,571 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 60,765 $ 72,910 Operating lease liabilities, current 11,660 10,184 Due to related party 2 11 Deferred revenue 1,251 1,061 Total current liabilities 73,678 84,166 Deferred tax liability, net — 3,118 Long-term debt, net — 34,189 Operating lease liabilities, non-current 16,143 13,374 Other long-term liabilities 8,810 8,713 Total liabilities 98,631 143,560 Commitments and Contingencies ( Note 14 ) Stockholders' Equity Preferred Stock, $ 0.001 par value, 50,000,000 shares authorized at June 30, 2025; 0 shares issued and outstanding at June 30, 2025 and December 31, 2024 — — Common Stock, $ 0.001 par value, 500,000,000 shares authorized, 165,273,651 and 162,871,266 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 165 163 Additional paid-in-capital 1,000,857 964,765 Accumulated other comprehensive income (loss) 1,446 ( 3,666 ) Retained earnings 71,150 46,749 Total stockholders' equity 1,073,618 1,008,011 Total liabilities and stoc

View Full Filing

View this 10-Q filing on SEC EDGAR